Understanding plasma treatment effect on human acyl-ghrelin concentrations

Area of Science:

• Biochemistry
• Endocrinology
• Analytical Chemistry

Background:

• Acyl-ghrelin is a key hormone regulating appetite and energy balance.
• Plasma acyl-ghrelin levels are susceptible to degradation, particularly during sample handling and storage.
• Standardized methods are crucial for accurate acyl-ghrelin measurement.

Purpose of the Study:

• To evaluate the impact of varying concentrations of AEBSF (esterase inhibitor) and acid treatment on acyl-ghrelin stability in human plasma.
• To determine optimal conditions for preserving acyl-ghrelin integrity through freeze-thaw cycles.
• To identify reliable methods for pre-analytical sample processing before acyl-ghrelin assays.

Main Methods:

• Human plasma samples were treated with different concentrations of AEBSF (0, 0.6, 1, 2 mg/ml).
• Half of the aliquots from each AEBSF treatment group were acidified with HCl.
• Samples were subjected to a freeze-thaw cycle and stored at -80°C prior to acyl-ghrelin measurement via ELISA.

Main Results:

• Treatment with 1 mg/ml AEBSF combined with HCl yielded significantly higher acyl-ghrelin levels compared to most other treatments.
• All HCl-treated samples showed increased acyl-ghrelin compared to their non-acidified counterparts.
• The combination of AEBSF and HCl demonstrated a more potent inhibition of ghrelin de-acylation than either agent alone.

Conclusions:

• A combination of 1 mg/ml AEBSF and HCl treatment is recommended for optimal acyl-ghrelin stability in human plasma subjected to freeze-thaw cycles.
• AEBSF and HCl synergistically enhance acyl-ghrelin preservation, minimizing degradation before analysis.
• These findings provide a standardized approach for sample preparation to ensure accurate acyl-ghrelin quantification.